Systems Biology in Reproductive Medicine · 2015 · 13 citations · 30 references
MedicineGeneticsHematologyImmunogeneticsMedical GeneticsStem Cell TransplantationDonor-recipient CompatibilityHematopoietic Stem Cell TransplantationHistocompatibilityHla TypingPreimplantation Genetic DiagnosisSideroblastic AnemiaCompatible Donor SelectionHereditary Sideroblastic AnemiaHla Antigen MatchingHla Compatibility AssessmentHuman Leukocyte Antigen TestingPreimplantation Genetic Testing DecisionsSlc25a38 Gene MutationsStem Cell Donor Matching
Preimplantation genetic diagnosis (PGD) to select histocompatible siblings to facilitate curative haematopoeitic stem-cell transplantation (HSCT) is now an acceptable option in the absence of an available human leukocyte antigen (HLA) compatible donor. We describe a case where the couple who requested HLA-PGD, were both carriers of two serious haematological diseases, beta-thalassaemia and sideroblastic anaemia. Their daughter, affected with sideroblastic anaemia, was programmed to have HSCT. A multiplex-fluorescent-touchdown-PCR protocol was optimized for the simultaneous amplification of: the two HBB-gene mutated regions (c.118C> T, c.25-26delAA), four short tandem repeats (STRs) in chr11p15.5 linked to the HBB gene, the SLC25A38 gene mutation (c.726C > T), two STRs in chr3p22.1 linked to the SLC25A38 gene, plus eleven informative STRs for HLA-haplotyping (chr6p22.1-21.3). This was followed by real-time nested PCR and high-resolution melting analysis (HRMA) for the detection of HBB and SLC25A38 gene mutations, as well as the analysis of all STRs on an automatic genetic analyzer (sequencer). The couple completed four clinical in vitro fertilization (IVF)/PGD cycles. At least one matched unaffected embryo was identified and transferred in each cycle. A twin pregnancy was established in the fourth PGD cycle and genotyping results at all loci were confirmed by prenatal diagnosis. Two healthy baby girls were delivered at week 38 of pregnancy. The need to exclude two familial disorders for HLA-PGD is rarely encountered. The methodological approach described here is fast, accurate, clinically-validated, and of relatively low cost.
30
Preimplantation Diagnosis for Fanconi Anemia Combined With HLA Matching
Yury Verlinsky · JAMA · 2001 · 488 citations
ESHRE PGD consortium best practice guidelines for amplification-based PGD
G. Harton, Martine De Rycke, Francesco Fiorentino et al. · Human Reproduction · 2010 · 231 citations